A unique pharmaceutical company
Orphan Europe, part of the Recordati group, is a unique pharmaceutical company focusing on the research and development of orphan medicinal products. Since 1990 we have used big thinking and extensive know-how on behalf of people affected by rare diseases. Patients and their families are central to our planning, our thinking and our actions. Recordati orphan drugs is present in the USA through its company Recordati Rare Diseases.
News and events
Satellite symposium organised by Orphan Europe at the SSIEM meeting in Innsbruck, Austria
Thursday 4 September 2014, 12.15–13.15, Saal Strassburg (ground floor)
click here for a personal message from Dr. Robin Lachmann, the Chairman of the symposium.
L’envol is part of the Hole in the Wall Camps network, a growing global network of innovative camps and programmes that provide life-changing experiences to children with serious medical conditions, always free of charge.